Rchr
J-GLOBAL ID:201801007267873880   Update date: Jan. 30, 2024

Takashi Fujimoto

Takashi Fujimoto
Affiliation and department:
Research field  (1): Neurosurgery
Research theme for competitive and other funds  (4):
  • 2020 - 2026 Drug development of central nervous system diseases using dynamic three-dimensional in vitro blood-brain barrier model
  • 2021 - 2024 Development of a Perfusion-Based 3D Blood-Brain Barrier Model for Analysis of Cancer Brain Metastasis and Pharmacokinetics
  • 2018 - 2023 血液脳関門保護をターゲットとした中枢神経疾患治療薬の開発
  • 2017 - 2022 Three dimensional blood-brain barrier model
Papers (26):
  • Kei Sato, Shinsuke Nakagawa, Yoichi Morofuji, Yuki Matsunaga, Takashi Fujimoto, Daisuke Watanabe, Tsuyoshi Izumo, Masami Niwa, Fruzsina R Walter, Judit P Vigh, et al. Effects of fasudil on blood-brain barrier integrity. Fluids and barriers of the CNS. 2022. 19. 1. 43-43
  • Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, Takashi Fujimoto, Kaishi Otsuka, Masami Niwa, Keisuke Tsutsumi. Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals (Basel, Switzerland). 2022. 15. 2
  • Kazuaki Okamura, Yoichi Morofuji, Nobutaka Horie, Tsuyoshi Izumo, Kei Sato, Takashi Fujimoto, Takayuki Matsuo. Hematoma expansion unrelated to rebleeding in ruptured anterior cerebral artery aneurysms treated by early endovascular embolization. Surgical Neurology International. 2021. 12. 571-571
  • 佐藤 慧, 諸藤 陽一, 中川 慎介, 藤本 隆史, 松永 裕希, 堀江 信貴, 出雲 剛, 松尾 孝之. 急性期脳梗塞治療としてのファスジル動注療法の可能性. 脳血管内治療. 2021. 6. Suppl. S134-S134
  • Tsuyoshi Izumo, Takashi Fujimoto, Yoichi Morofuji, Yohei Tateishi, Takayuki Matsuo. Partial Clipping Occlusion Including Rupture Point Is an Effective Strategy for Ruptured Giant Fusiform Basilar Artery Aneurysm: A Technical Case Report. Frontiers in Neurology. 2021. 12
more...
MISC (1):
  • 諸藤陽一, 中川慎介, 藤本隆史, 佐藤慧, 松永裕希, 堀江信貴, 出雲剛, 松尾孝之. 急性期脳梗塞治療としてのファスジル動注療法の可能性. 脳血管内治療(Web). 2020. 5. Supplement
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page